Nov 27, 2021

Starpharma Announces Encouraging Interim Results for Prostate Cancer Drug

Gene Online reports on the news of Starpharma's latest announcement - the release of positive interim results from the prostate cancer cohort of Starpharma's ongoing phase 2 trial of DEP® cabazitaxel. Read the article here. 

 This contains certain forward-looking statements.